Zio vs Octagos

Zio is a patch worn on the skin. A deep neural network analyzes the recording in the cloud, qualified cardiac technicians validate the preliminary findings, and a physician report follows. The publicly traded parent, iRhythm Holdings, bills payers through Medicare-enrolled IDTFs, and no public price is listed. OpenFDA lists 18 510(k) records, the latest being the ZEUS Platform, K252859, decided in May 2026. A cardiology practice ordering ambulatory ECG monitoring for suspected arrhythmias buys it.

Octagos, a Houston company founded by practicing electrophysiologist Shanti Bansal, MD, works on what implanted pacemakers and defibrillators transmit. Clinics following those devices are its customers, and a practice that also runs an ambulatory ECG program could buy both for separate workloads. Its pricing page names four tiers, Pro as software only, Premium adding clinical and patient engagement services, Flex for on-demand services and Custom. Billing options are per billable transmission, a fixed monthly fee or a custom plan. The vendor claims an average of 21 days to EHR go-live.